Liikanen gets briefing on industry's wishes:
This article was originally published in Clinica
European industry presented its regulatory wish list to DG Enterprise Commissioner Erkki Liikanen last week in Brussels. In what was a landmark meeting, representatives from Guidant, ISOTIS, Impella, ELA Medical and Siemens Medical joined EUCOMED director-general Michael Baker, EDMA president Professor Uwe Bicker and a representative from COCIR in what was anticipated to be a valuable first exchange of views on a broad range of subjects. The needs for separate regulation from pharma, an appropriate regulatory framework and favourable single market conditions for SMEs were among the agenda points. More details in next week's Clinica.
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.